BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7401440)

  • 1. [Effectiveness of nonachlazine in ischemic heart disease under ambulatory conditions].
    Glezer GA; Shraĭber NM; Pak GP; Moskalenko NP
    Kardiologiia; 1980 Jul; 20(7):53-6. PubMed ID: 7401440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonachlazine in solution as an arresting agent in stenocardiac attacks].
    Boĭko SS; Kaverina NV; Liubimov BI; Markova GA; Mitrofanov VS
    Farmakol Toksikol; 1979; 42(3):243-7. PubMed ID: 446702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of nonachlazine and oxyphedrin on a focus of myocardial ischemia].
    Chichkanov GG; Bogolepov AK
    Biull Eksp Biol Med; 1978 Dec; 86(12):691-4. PubMed ID: 728611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of nonachlazine in the treatment of chronic ischemic heart disease].
    Evtushenko VI; Zakharov NM; Knysh VI; Martynov VI
    Voen Med Zh; 1979 Mar; (3):59-60. PubMed ID: 452467
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological and clinical study of the liquid drug form of nonachlazine].
    Kniazev MD; Kaverina NV; Aslibekian IS; Kirichenko AA; Vorovkov AI
    Kardiologiia; 1979 Oct; 19(10):14-7. PubMed ID: 502162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Certain debatable questions concerning the use of nonachlazine in patients with chronic ischemic heart disease].
    Iagus KhK
    Ter Arkh; 1980; 52(9):97-101. PubMed ID: 7434242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibility of the pharmacologic treatment of post-ischemic myocardial damage].
    Rozonov IuB; Morozova TV; Markin VA; Pokazeeva ZT
    Biull Eksp Biol Med; 1986 Sep; 102(9):301-3. PubMed ID: 3756329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of the inotropic action of nonachlazine].
    Kaverina NV; Katsenovich RA; Tkachenko BI; Iunusov ZZ; Ovsiannikov VI
    Farmakol Toksikol; 1985; 48(1):23-7. PubMed ID: 3979531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral vasodilators and beta-stimulants in the treatment of the initial stages of chronic circulatory insufficiency].
    Shevchenko VA
    Vrach Delo; 1987 Sep; (9):15-8. PubMed ID: 3424762
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of nonachlazine on the creatine phosphokinase and acid phosphatase activity and on the lysosomal membrane stability of the ischemic myocardium in rats after preliminary reserpinization].
    Sysoliatina NA
    Farmakol Toksikol; 1986; 49(4):77-81. PubMed ID: 3758337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of nonachlazine on the echocardiographic parameters in patients with post-infarct cardiosclerosis].
    Iagus KhK
    Ter Arkh; 1980; 52(5):42-6. PubMed ID: 7404363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of nonachlazine on ATP, ADP, and lactic acid concentration in intact and ischemic myocardium].
    Turilova AI; Azvolinskaia TN; Kryzhanovskiĭ SA
    Biull Eksp Biol Med; 1980 Jul; 89(7):49-51. PubMed ID: 7407371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of nonachlazine on systemic hemodynamics and the collateral coronary circulation in acute myocardial ischemia].
    Pilipchuk DB; Berger DIa; Sapozhkov AV
    Farmakol Toksikol; 1980; 43(3):324-7. PubMed ID: 7449970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
    Piatak OA; Yanovskii GV; Lizogub VG
    Cor Vasa; 1991; 33(1):19-25. PubMed ID: 1655353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
    Tereshchenko VP
    Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of action of nonachlazine and ethmozine on the cardiac blood supply in acute myocardial ischemia].
    Pilipchuk DB
    Farmakol Toksikol; 1981; 44(1):63-7. PubMed ID: 7021174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Partner control" method of twin studies in evaluating the hemodynamic effects of nonachlazine].
    Zaslavskaia RM; Zolotaia RD; Lil'in ET
    Farmakol Toksikol; 1981; 44(3):357-60. PubMed ID: 7026276
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of the antianginal action of nonachlazine].
    Chumburidze VB
    Farmakol Toksikol; 1976; 39(1):46-50. PubMed ID: 943317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.